scholarly journals Ontogeny of different subsets of yellow fever virus-specific circulatory CXCR5+ CD4+ T cells after yellow fever vaccination

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Quinn DeGottardi ◽  
Theresa J. Gates ◽  
Junbao Yang ◽  
Eddie A. James ◽  
Uma Malhotra ◽  
...  

Abstract Monitoring the frequency of circulatory CXCR5+ (cCXCR5+) CD4+ T cells in periphery blood provides a potential biomarker to draw inferences about T follicular helper (TFH) activity within germinal center. However, cCXCR5+ T cells are highly heterogeneous in their expression of ICOS, PD1 and CD38 and the relationship between different cCXCR5 subsets as delineated by these markers remains unclear. We applied class II tetramer reagents and mass cytometry to investigate the ontogeny of different subsets of cCXCR5+ T cell following yellow fever immunization. Through unsupervised analyses of mass cytometry data, we show yellow fever virus-specific cCXCR5 T cells elicited by vaccination were initially CD38+ICOS+PD1+, but then transitioned to become CD38+ICOS−PD1+ and CD38−ICOS−PD1+ before coming to rest as a CD38−ICOS−PD1− subset. These results imply that most antigen-specific cCXCR5+ T cells, including the CD38−ICOS−PD1− CXCR5+ T cells are derived from the CXCR5+CD38+ICOS+PD1+ subset, the subset that most resembles preTFH/TFH in the germinal center.

1930 ◽  
Vol 51 (3) ◽  
pp. 493-517 ◽  
Author(s):  
W. A. Sawyer ◽  
S. F. Kitchen ◽  
Martin Frobisher ◽  
Wray Lloyd

1. The yellow fever now in South America, the present yellow fever of Africa and the historic yellow fever of Panama and other American countries are the same disease. This conclusion is based on cross immunity tests in monkeys with strains of yellow fever virus from Africa and Brazil and on tests of sera from 25 persons, who had recovered from yellow fever in various places and at various times, for the power to protect monkeys against African or Brazilian virus strains. 2. Cases of leptospiral jaundice (Weil's disease) were present among those diagnosed as yellow fever in the recent epidemic in Rio de Janeiro. This is shown by the isolation of cultures of leptospirae from the blood of two patients by H. R. Muller and E. B. Tilden of The Rockefeller Institute, and by the demonstration by us of protective power against leptospirae and absence of protective power against yellow fever virus in the sera from two persons after recovery. The isolation of leptospirae by Noguchi and other investigators from the blood of occasional patients in past epidemics of yellow fever in a number of American countries indicates that leptospiral jaundice was present then as well and was diagnosed clinically as yellow fever. 3. The absence of protective power against leptospirae shown by the Brazilian sera which protected against yellow fever virus and the absence of protective power against yellow fever virus in the sera that protected against leptospirae point to the probability that American yellow fever is not the combined effect of leptospirae and yellow fever virus. The position of L. icteroides, isolated by Noguchi during yellow fever epidemics, now appears to be not that of a secondary invading microorganism in cases of virus yellow fever, but that of the incitant of a form of infectious jaundice, sometimes fatal, often coincident in its appearance with typical yellow fever and apparently indistinguishable from it clinically. This leptospiral disease has not hitherto been separated from true yellow fever. Noguchi's discoveries become; therefore, of the greatest significance in respect to the epidemiology and causation of yellow fever and of infectious jaundice, previously confused one with the other. In all outbreaks of supposed yellow fever hereafter the existence of the two kinds of jaundice, one due to yellow fever virus and the other to leptospirae will have to be taken into account. Only the former probably is spread by mosquitoes and requires anti-mosquito measures for its control. 4. The only difference observed by us between the American and African strains of yellow fever virus was a pronounced difference in virulence for monkeys. The virulence of the two African strains studied was very high while that of the one American strain was highly variable and usually low.


2012 ◽  
Vol 87 (6) ◽  
pp. 1112-1115 ◽  
Author(s):  
Katherine B. Gibney ◽  
Olga I. Kosoy ◽  
Marc Fischer ◽  
Srilatha Edupuganti ◽  
Robert S. Lanciotti ◽  
...  

Vaccine ◽  
2021 ◽  
Author(s):  
Laise Rodrigues Reis ◽  
Ismael Artur da Costa-Rocha ◽  
Ana Carolina Campi-Azevedo ◽  
Vanessa Peruhype-Magalhães ◽  
Jordana Grazziela Coelho-dos-Reis ◽  
...  

Vaccines ◽  
2019 ◽  
Vol 7 (4) ◽  
pp. 206
Author(s):  
Izabela Maurício de Rezende ◽  
Pedro Augusto Alves ◽  
Matheus Soares Arruda ◽  
Andreza Parreiras Gonçalves ◽  
Gabriela Fernanda Garcia Oliveira ◽  
...  

The yellow fever (YF) vaccine consists of an attenuated virus, and despite its relative safety, some adverse events following YF vaccination have been described. At the end of 2016, Brazil experienced the most massive sylvatic yellow fever outbreak over the last 70 years and an intense campaign of YF vaccination occurred in Minas Gerais state in Southeast Brazil from 2016 to 2018. The present study aimed to develop a genotyping tool and investigate 21 cases of suspected adverse events following YF vaccination. Initial in silico analyses were performed using partial NS5 nucleotide sequences to verify the discriminatory potential between wild-type and vaccine viruses. Samples from patients were screened for the presence of the YFV RNA, using 5′UTR as the target, and then used for amplification of partial NS5 gene amplification, sequencing, and phylogenetic analysis. Genotyping indicated that 17 suspected cases were infected by the wild-type yellow fever virus, but four cases remained inconclusive. The genotyping tool was efficient in distinguishing the vaccine from wild-type virus, and it has the potential to be used for the differentiation of all yellow fever virus genotypes.


2014 ◽  
Vol 194 (3) ◽  
pp. 1141-1153 ◽  
Author(s):  
Maria R. Bassi ◽  
Michael Kongsgaard ◽  
Maria A. Steffensen ◽  
Christina Fenger ◽  
Michael Rasmussen ◽  
...  

2019 ◽  
Author(s):  
Nicole S. Torosin ◽  
Timothy H. Webster ◽  
Hernan Argibay ◽  
Hebe Ferreyra ◽  
Marcela Uhart ◽  
...  

1AbstractIn 2007-2009, a ma jor yellow fever virus (YFV) outbreak in Northern Argentina decimated the local howler monkey (Alouatta) population. We explored the relationship between Toll-like receptor (TLR) 7 and TLR8 gene variation and YFV susceptibility using samples from Alouatta individuals alive before the YFV outbreak, individuals that died during the outbreak, and individuals that survived the outbreak and are alive today. We measured genetic divergence between Alouatta YFV exposure groups and evaluated Alouatta-specific substitutions for functional consequences. We did not find different allele frequencies in the post-YFV exposure Alouatta group compared to the pre-exposure group. However, we identified three nonsynonymous variants in TLR7 in A. guariba clamitans. Two of these substitutions are under positive selection in functionally important regions of the gene. These unique coding differences in A. guariba clamitans may affect YFV resistance, but more work is necessary to fully explore this hypothesis.


2016 ◽  
Vol 10 (5) ◽  
pp. e0004709 ◽  
Author(s):  
Yu Cong ◽  
Monica A. McArthur ◽  
Melanie Cohen ◽  
Peter B. Jahrling ◽  
Krisztina B. Janosko ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document